Browsing by Subject "Dosage imbalance"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Sex-specific trisomic Dyrk1a-related skeletal phenotypes during development in a Down syndrome model
    (The Company of Biologists, 2024) LaCombe, Jonathan M.; Sloan, Kourtney; Thomas, Jared R.; Blackwell, Matthew P.; Crawford, Isabella; Bishop, Flannery; Wallace, Joseph M.; Roper, Randall J.; Biology, School of Science
    Skeletal insufficiency affects all individuals with Down syndrome (DS) or trisomy 21 and may alter bone strength throughout development due to a reduced period of bone formation and early attainment of peak bone mass compared to those in typically developing individuals. Appendicular skeletal deficits also appear in males before females with DS. In femurs of male Ts65Dn DS model mice, cortical deficits were pronounced throughout development, but trabecular deficits and Dyrk1a overexpression were transitory until postnatal day (P) 30, when there were persistent trabecular and cortical deficits and Dyrk1a was trending toward overexpression. Correction of DS-related skeletal deficits by a purported DYRK1A inhibitor or through genetic means beginning at P21 was not effective at P30, but germline normalization of Dyrk1a improved male bone structure by P36. Trabecular and cortical deficits in female Ts65Dn mice were evident at P30 but subsided by P36, typifying periodic developmental skeletal normalizations that progressed to more prominent bone deficiencies. Sex-dependent differences in skeletal deficits with a delayed impact of trisomic Dyrk1a are important to find temporally specific treatment periods for bone and other phenotypes associated with trisomy 21.